## Elizabeth Wood, PhD

>Elizabeth Wood is the co-founder and director of [JURA Bio, Inc.](https://www.jurabio.com), an early-stage therapeutics start up focusing on developing and delivering cell-based therapies for the treatment of autoimmune and immune-related neurodegenerative disease. Before starting JURA, Wood was a post-doc in the lab of [Adam Cohen](http://cohenweb.rc.fas.harvard.edu/) at Harvard's Department of Chemistry and Physics. She began her PhD with [Angela Belcher](http://belcherlab.mit.edu/) and [Markus Buehler](http://lamm.mit.edu/) at MIT, and finished it under the supervision of [Claus Helix-Nielsen](https://scholar.google.com/citations?user=VLFQdvsAAAAJ&hl=en) at The Technical University of Denmark, Departments of Physics and Civil and Environmental Engineering. She has also worked at the University of Copenhagenâ€™s SBiN Lab with [Kresten Lindorff-Larsen](https://www1.bio.ku.dk/english/research/bms/research/sbinlab/groups/kll/), integrating computational methods with experimental studies to better predict RNA structure and to understand how the ability of proteins to change their shape helps modulate their function.
 
>Wood is a visiting scientist at the [Broad Institute](https://www.broadinstitute.org/), where she serves on the steering committee of [MIA](https://www.broadinstitute.org/MIA). Since 2019 she has served as the primary organizer of the NeurIPS Workshop [Learning Meaningful Representations of Life](https://lmrl.org). She currently serves on the board of [Pure Home Water Ghana](https://purehomewater.org/) and [Project Clio](https://projectclio.org/).


[Google Scholar](https://scholar.google.com/citations?user=v32AeGgAAAAJ&hl=en), [Linkedin](https://www.linkedin.com/in/elizabethwood/), and [Twitter](https://www.twitter.com/lizbwood)
